Clinical Trials at UBMD Neurology
During the past decade, UBMD Neurology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UBMD Neurology" #1 sponsor was "Celgene" with 1 trials, followed by "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 1 trials
sponsored, "MedDay Pharmaceuticals SA" with 1 trials sponsored, "SK Life Science, Inc." with 1 trials sponsored and "TauRx Therapeutics Ltd"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at UBMD Neurology
According to Clinical.Site data, the most researched conditions in "UBMD Neurology" are
"Alzheimer Disease" (2 trials), "Multiple Sclerosis" (2 trials) and "Primary Generalized Epilepsy" (1 trials). Many other conditions were trialed in "UBMD Neurology" in a lesser frequency.
Clinical Trials Intervention Types at UBMD Neurology
Most popular intervention types in "UBMD Neurology" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Cenobamate" (1 trials), "GV-971" (1 trials), "MD1003 100mg capsule" (1 trials) and "PLACEBO" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UBMD Neurology
The vast majority of trials in "UBMD Neurology" are
5 trials for "All" genders.
Clinical Trials Status at UBMD Neurology
Currently, there are NaN active trials in "UBMD Neurology".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UBMD Neurology,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UBMD Neurology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".